Healthcare · Nasdaq · AI-powered stock analysis, 32-signal quality score, SEC EDGAR financials, and institutional holdings. Updated .
Apogee Therapeutics, Inc. (APGE) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. APGE is not currently included in 13F Pro's AI-ranked quality universe — this company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. rankings refresh on jan 1, apr 1, jul 1, oct 1. Top institutional holders of APGE by reported 13-F value include VR Adviser, BlackRock, HBK INVESTMENTS L P, based on the most recent SEC filings. APGE trades on the Nasdaq exchange and files with the SEC under CIK 1974640. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate APGE daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for Apogee Therapeutics, Inc. directly from SEC EDGAR.
| Institution | Shares | Value | Reported |
|---|---|---|---|
| VR Adviser | 8,493,321 | $1.1B | 2026-06-30 |
| BlackRock | 5,507,032 | $730.9M | 2026-06-30 |
| HBK INVESTMENTS L P | 2,850,000 | $378.3M | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT | 2,572,119 | $341.4M | 2026-06-30 |
| FMR | 2,493,137 | $330.9M | 2026-06-30 |
| STATE STREET | 2,297,743 | $305.0M | 2026-06-30 |
| DRIEHAUS CAPITAL MANAGEMENT | 1,740,101 | $231.0M | 2026-06-30 |
| GOLDMAN SACHS GROUP | 1,693,341 | $224.8M | 2026-06-30 |
| BALYASNY ASSET MANAGEMENT L.P. | 1,665,102 | $221.0M | 2026-06-30 |
| GLAZER CAPITAL | 1,641,042 | $217.8M | 2026-06-30 |
13F Pro Quality Score
Pending next ranking run
This company passes all size and coverage filters but hasn't been included in the latest quarterly ranking run. Rankings refresh on Jan 1, Apr 1, Jul 1, Oct 1.
Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.
Financial metrics will appear once SEC EDGAR data is ingested for this company.